Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1956 1
1960 2
1961 1
1968 2
1969 1
1970 1
1971 1
1973 1
1974 2
1975 2
1976 3
1977 1
1978 3
1979 2
1980 1
1981 4
1982 3
1983 5
1984 4
1986 2
1987 3
1988 3
1989 3
1990 6
1991 1
1992 6
1993 4
1994 6
1995 4
1996 3
1997 6
1998 5
1999 7
2000 3
2001 3
2002 2
2003 2
2006 1
2007 1
2008 1
2009 3
2010 5
2011 9
2012 5
2013 6
2014 6
2015 1
2016 3
2017 4
2018 7
2019 10
2020 14
2021 13
2022 16
2023 14
2024 24
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Oncogenic ETS Factors in Prostate Cancer.
Nicholas TR, Strittmatter BG, Hollenhorst PC. Nicholas TR, et al. Adv Exp Med Biol. 2019;1210:409-436. doi: 10.1007/978-3-030-32656-2_18. Adv Exp Med Biol. 2019. PMID: 31900919 Review.
Peace in Health Care.
Nicholas T, Holt G. Nicholas T, et al. AMA J Ethics. 2024 Nov 1;26(11):E825-827. doi: 10.1001/amajethics.2024.825. AMA J Ethics. 2024. PMID: 39495638 Free article. No abstract available.
Screening and Intervention to Prevent Falls and Fractures in Older People.
Lamb SE, Bruce J, Hossain A, Ji C, Longo R, Lall R, Bojke C, Hulme C, Withers E, Finnegan S, Sheridan R, Willett K, Underwood M; Prevention of Fall Injury Trial Study Group. Lamb SE, et al. N Engl J Med. 2020 Nov 5;383(19):1848-1859. doi: 10.1056/NEJMoa2001500. N Engl J Med. 2020. PMID: 33211928 Clinical Trial.
A familial, telomere-to-telomere reference for human de novo mutation and recombination from a four-generation pedigree.
Porubsky D, Dashnow H, Sasani TA, Logsdon GA, Hallast P, Noyes MD, Kronenberg ZN, Mokveld T, Koundinya N, Nolan C, Steely CJ, Guarracino A, Dolzhenko E, Harvey WT, Rowell WJ, Grigorev K, Nicholas TJ, Oshima KK, Lin J, Ebert P, Watkins WS, Leung TY, Hanlon VCT, McGee S, Pedersen BS, Goldberg ME, Happ HC, Jeong H, Munson KM, Hoekzema K, Chan DD, Wang Y, Knuth J, Garcia GH, Fanslow C, Lambert C, Lee C, Smith JD, Levy S, Mason CE, Garrison E, Lansdorp PM, Neklason DW, Jorde LB, Quinlan AR, Eberle MA, Eichler EE. Porubsky D, et al. Among authors: nicholas tj. bioRxiv [Preprint]. 2024 Aug 5:2024.08.05.606142. doi: 10.1101/2024.08.05.606142. bioRxiv. 2024. PMID: 39149261 Free PMC article. Preprint.
Human de novo mutation rates from a four-generation pedigree reference.
Porubsky D, Dashnow H, Sasani TA, Logsdon GA, Hallast P, Noyes MD, Kronenberg ZN, Mokveld T, Koundinya N, Nolan C, Steely CJ, Guarracino A, Dolzhenko E, Harvey WT, Rowell WJ, Grigorev K, Nicholas TJ, Goldberg ME, Oshima KK, Lin J, Ebert P, Watkins WS, Leung TY, Hanlon VCT, McGee S, Pedersen BS, Happ HC, Jeong H, Munson KM, Hoekzema K, Chan DD, Wang Y, Knuth J, Garcia GH, Fanslow C, Lambert C, Lee C, Smith JD, Levy S, Mason CE, Garrison E, Lansdorp PM, Neklason DW, Jorde LB, Quinlan AR, Eberle MA, Eichler EE. Porubsky D, et al. Among authors: nicholas tj. Nature. 2025 Jul;643(8071):427-436. doi: 10.1038/s41586-025-08922-2. Epub 2025 Apr 23. Nature. 2025. PMID: 40269156 Free PMC article.
Role of Disease Progression Models in Drug Development.
Barrett JS, Nicholas T, Azer K, Corrigan BW. Barrett JS, et al. Among authors: nicholas t. Pharm Res. 2022 Aug;39(8):1803-1815. doi: 10.1007/s11095-022-03257-3. Epub 2022 Apr 11. Pharm Res. 2022. PMID: 35411507 Free PMC article. Review.
A genome-wide approach for the discovery of novel repeat expansion disorders in the Undiagnosed Diseases Network cohort.
Fazal S, Dashnow H, Dohrn MF, Raposo J, Hiatt L, Danzi MC, Xu IRL, Toro C, Adams DR, Usdin K, Hayward B, Kobren SN, Sunyaev SR, Spillmann RC, Shashi V, Rebelo A, Bademci G; Undiagnosed Diseases Network; Tekin M, Quinlan AR, Zuchner S. Fazal S, et al. Genet Med. 2025 Aug;27(8):101462. doi: 10.1016/j.gim.2025.101462. Epub 2025 May 22. Genet Med. 2025. PMID: 40417743
259 results